Dietary intake of the flower extracts of German chamomile (Matricaria recutita L.) inhibited compound 48/80-induced itch-scratch responses in mice.
暂无分享,去创建一个
Y. Kobayashi | Y. Nakano | T. Kamiya | K. Inayama | A. Sakai
[1] C. Niemegeers,et al. Oxatomide, a new orally active drug which inhibits both the release and the effects of allergic mediators , 1977, Experientia.
[2] X. Hua,et al. Inhibition of compound 48/80 — induced vascular protein leakage by pretreatment with capsaicin and a substance P antagonist , 1984, Naunyn-Schmiedeberg's Archives of Pharmacology.
[3] J. Thiele. Oxidative Targets in the Stratum corneum , 2001, Skin Pharmacology and Physiology.
[4] N. Inagaki,et al. Scratching Behavior in Various Strains of Mice , 2001, Skin Pharmacology and Physiology.
[5] M. Yuzurihara,et al. Effects of an oriental herbal medicine, "Saiboku-to", and its constituent herbs on Compound 48/80-induced histamine release from peritoneal mast cells in rats. , 2001, Phytomedicine : international journal of phytotherapy and phytopharmacology.
[6] N. Inagaki,et al. Evaluation of anti-scratch properties of oxatomide and epinastine in mice. , 2000, European journal of pharmacology.
[7] C. Wahlgren. Itch and Atopic Dermatitis: An Overview , 1999, The Journal of dermatology.
[8] Y. Ohta,et al. Role of endogenous serotonin and histamine in the pathogenesis of gastric mucosal lesions in unanaesthetised rats with a single treatment of compound 48/80, a mast cell degranulator. , 1999, Pharmacological research.
[9] R. Scholten,et al. The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines , 1999, Annals of Internal Medicine.
[10] M. Furue. [Atopic dermatitis--historical and immunological background]. , 1998, Fukuoka igaku zasshi = Hukuoka acta medica.
[11] H. Handwerker,et al. Histamine-induced itch and alloknesis (itchy skin) in atopic eczema patients and controls. , 1995, Acta dermato-venereologica.
[12] T. Nagasawa,et al. Scratching behavior induced by pruritogenic but not algesiogenic agents in mice. , 1995, European journal of pharmacology.
[13] C. Chiang,et al. Stimulation of inositol phosphate production and GTPase activity by compound 48/80 in rat peritoneal mast cells. , 1993, Biochemical and biophysical research communications.
[14] C. Wahlgren. Pathophysiology of itching in urticaria and atopic dermatitis , 1992, Allergy.
[15] N. Soter,et al. Mast-cell heterogeneity: functional comparison of purified mouse cutaneous and peritoneal mast cells. , 1990, The Journal of investigative dermatology.
[16] R. Bergström,et al. The antipruritic effect of a sedative and a non‐sedative antihistamine in atopic dermatitis , 1990, The British journal of dermatology.
[17] J. Berth-Jones,et al. Failure of terfenadine in relieving the pruritus of atopic dermatitis , 1989, The British journal of dermatology.
[18] S. Toda,et al. Effects of the Chinese herbal medicine "saiboku-to" on histamine release from and the degranulation of mouse peritoneal mast cells induced by compound 48/80. , 1988, Journal of ethnopharmacology.
[19] K E Barrett,et al. Studies on histamine secretion from enzymically dispersed cutaneous mast cells of the rat. , 1985, The Journal of investigative dermatology.
[20] A. Wüthrich,et al. Compound 48/80 is a selective and powerful inhibitor of calmodulin-regulated functions. , 1983, Biochimica et biophysica acta.
[21] B. Fjellner,et al. Studies on pruritogenic and histamine-releasing effects of some putative peptide neurotransmitters. , 1981, Acta dermato-venereologica.